Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.7400
-0.0200 (-2.63%)
Apr 22, 2026, 3:30 PM EST
Vaxart Market Cap
Vaxart has a market cap or net worth of $178.13 million as of April 23, 2026. Its market cap has increased by 150.91% in one year.
Market Cap
178.13M
Enterprise Value
127.37M
Revenue
237.26M
Ranking
n/a
PE Ratio
10.55
Stock Price
$0.74
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 178.13M, an increase of 195.17%. That is a compound annual growth rate of 14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 178.13M | 114.29% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 508.16M |
| Silence Therapeutics | 355.67M |
| Northwest Biotherapeutics | 318.36M |
| HST Global | 88.40M |
| BioStem Technologies | 84.28M |
| Nuo Therapeutics | 72.60M |
| Cell Source | 63.19M |
| Vicapsys Life Sciences | 47.26M |